293 related articles for article (PubMed ID: 23934350)
21. Indirect biomarkers of blood doping: A systematic review.
Krumm B; Saugy JJ; Botrè F; Donati F; Faiss R
Drug Test Anal; 2024 Jan; 16(1):49-64. PubMed ID: 37160638
[TBL] [Abstract][Full Text] [Related]
22. Contemporary blood doping-Performance, mechanism, and detection.
Breenfeldt Andersen A; Nordsborg NB; Bonne TC; Bejder J
Scand J Med Sci Sports; 2024 Jan; 34(1):e14243. PubMed ID: 36229224
[TBL] [Abstract][Full Text] [Related]
23. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
[TBL] [Abstract][Full Text] [Related]
24. Do athletes have a right to access data in their Athlete Biological Passport?
Devriendt T; Chokoshvili D; Favaretto M; Borry P
Drug Test Anal; 2018 May; 10(5):802-806. PubMed ID: 29524351
[TBL] [Abstract][Full Text] [Related]
25. The athlete biological passport: ticket to a fair Commonwealth Games.
Bucknall V; Rehman H; Bassindale T; Clement RG
Scott Med J; 2014 Aug; 59(3):143-8. PubMed ID: 25187193
[TBL] [Abstract][Full Text] [Related]
26. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
Leuenberger N; Reichel C; Lasne F
Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
[TBL] [Abstract][Full Text] [Related]
27. Challenges and perspectives in anti-doping testing.
Schamasch P; Rabin O
Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers: unrealized potential in sports doping analysis.
Teale P; Barton C; Driver PM; Kay RG
Bioanalysis; 2009 Sep; 1(6):1103-18. PubMed ID: 21083078
[TBL] [Abstract][Full Text] [Related]
29. [Faster, higher, stronger: knowledge about old and new doping substances].
Pieters T; de Hon O
Ned Tijdschr Geneeskd; 2013; 157(28):A6450. PubMed ID: 23841931
[TBL] [Abstract][Full Text] [Related]
30. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016.
Aquino Neto FR; Sarderla VF; Mirotti L; Pizzatti L
Bioanalysis; 2016 Sep; 8(17):1753-6. PubMed ID: 27491844
[No Abstract] [Full Text] [Related]
31. A role for metabolomics in the antidoping toolbox?
Narduzzi L; Dervilly G; Audran M; Le Bizec B; Buisson C
Drug Test Anal; 2020 Jun; 12(6):677-690. PubMed ID: 32144900
[TBL] [Abstract][Full Text] [Related]
32. Scientific expertise and the Athlete Biological Passport: 3 years of experience.
Schumacher YO; d'Onofrio G
Clin Chem; 2012 Jun; 58(6):979-85. PubMed ID: 22490304
[TBL] [Abstract][Full Text] [Related]
33. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H; Schänzer W
Drug Test Anal; 2014; 6(1-2):164-84. PubMed ID: 24285613
[TBL] [Abstract][Full Text] [Related]
34. Blood doping: the flip side of transfusion and transfusion alternatives.
Cacic DL; Hervig T; Seghatchian J
Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798
[TBL] [Abstract][Full Text] [Related]
35. Application of the Athlete Biological Passport Approach to the Detection of Growth Hormone Doping.
Equey T; Pastor A; de la Torre Fornell R; Thomas A; Giraud S; Thevis M; Kuuranne T; Baume N; Barroso O; Aikin R
J Clin Endocrinol Metab; 2022 Feb; 107(3):649-659. PubMed ID: 34726230
[TBL] [Abstract][Full Text] [Related]
36. A false start in the race against doping in sport: concerns with cycling's biological passport.
Hailey N
Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
[TBL] [Abstract][Full Text] [Related]
37. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
Harcourt PR; Marclay F; Clothier B
Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone doping in sports: a critical review of use and detection strategies.
Baumann GP
Endocr Rev; 2012 Apr; 33(2):155-86. PubMed ID: 22368183
[TBL] [Abstract][Full Text] [Related]
39. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
Nikolopoulos DD; Spiliopoulou C; Theocharis SE
Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
[TBL] [Abstract][Full Text] [Related]
40. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
